Tenaya Therapeutics to Participate at Chardans 7th Annual Genetic Medicines and Cell

SOUTH SAN FRANCISCO, Calif., April 21, 2023 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Chief Executive Officer, will participate at Chardan’s…Read More